DENAXA 60MG INJECTION

Denaxa 60mg injection is made up of an active component called Denosumab. It is a medicine for treating osteoporosis, characterized by weak bones. It’s also used to avoid bone problems in patients with certain forms of cancers, like bone metastases and myeloma. Denaxa 60 mg injection works by inhibiting a protein known as RANK, the ligand involved in the destruction of the bone. Research has shown that it can increase bone density while also decreasing the risk of fractures in postmenopausal females with osteoporosis, as well as those suffering from osteoporosis-related loss in bone. Close monitoring of renal function could be required in patients with moderate impairment in their renal function.
People with a history of hypersensitivity or allergic reactions to the components shouldn’t use Denaxa 60mg injection. Proper vitamin D and calcium supplementation intake is essential to ensure the treatment. It is not recommended for use in children and adolescents. The safety and efficacy of this medication in the pediatric population have not been proven. Therefore, it is not recommended for those under 18 years old. The medication should be utilized carefully in patients with pre-existing hypoparathyroidism characterized by a low level of parathyroid hormone.